A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

356

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Schizophrenia
Interventions
DRUG

Lurasidone 20 mg

Lurasidone 20mg/day tablets

DRUG

Lurasidone 40mg

Lurasidone 40mg/day tablets

DRUG

Lurasidone 80 mg

Lurasidone 80mg/day - 2 40mg tablets

DRUG

Haloperidol 10mg

Haloperidol 10mg/day tablets

DRUG

Placebo

Matching Placebo to Lurasdione and Haloperidol

Trial Locations (34)

19139

Quantum Clinical Services Group, Philadelphia

19141

Albert Einstein Medical Center - Dept. of Psychiatry, Philadelphia

20016

Comprehensive Neuroscience. Inc., Washington D.C.

20850

Centers for Behavioral Health, LLC, Rockville

22041

CNS, Inc., Falls Church

30080

Carman Research, Smyrna

30308

Atlanta Center for Medical Research, Atlanta

32789

Coordinated Research of Florida, Inc., Winter Park

32935

Comprehensive Neuroscience. Inc., Melbourne

33161

Segal Institute for Clinical Research, North Miami

33613

University of South Florida, Tampa

35209

Birmingham Psychiatry Pharmaceutical, Birmingham

45267

Psychiatric Professional Services Inc, Cincinnati

53210

Medstream, Inc., Milwaukee

60194

Alexian Brothers Behavioral Health Hospital, Hoffman Estates

60523

American Medical Research, Oak Brook

75235

St. Paul Medical Center, Dallas

University Hills Clinical Research, Dallas

77401

Claghorn Lesem Research Clinic, Inc., Bellaire

78756

Community Clinical Research, Austin

FutureSearch Trials, Austin

89030

Lake Mead Hospital, North Las Vegas

90703

Institute for Psychopharmacology Research, Cerritos

91206

California Clinical Trials Medical Group, Glendale

91942

Optimum Health Services, La Mesa

92108

Affiliated Research Institute, San Diego

92123

Sharp Mesa Vista Hospital, San Diego

92126

California Neuropsychopharmacolgoy Clinical Research Insitute, San Diego

92845

CNS Network, Garden Grove

92868

University of California, Irvine, Orange

96826

Hawaii Research Center, Honolulu

98004

Northwest Clinical Research Center, Belleview

08021

Comprehensive Clinical Research CNS, PC, Clementon

07033

ClinSearch, Inc., Kenilworth

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00044044 - A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter